๐”– Scriptorium
โœฆ   LIBER   โœฆ

๐Ÿ“

Multiple sclerosis for the practicing neurologist

โœ Scribed by Joel Oger; et al


Publisher
Demos
Year
2007
Tongue
English
Leaves
125
Series
World Federation of Neurology seminars in clinical neurology, v. 5
Category
Library

โฌ‡  Acquire This Volume

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Multiple Sclerosis for the Non-Neurologi
โœ Mary Ann Picone ๐Ÿ“‚ Library ๐Ÿ“… 2019 ๐Ÿ› Wolters Kluwer ๐ŸŒ English

Recent rapid changes in the field of multiple sclerosis management have made the task of staying well-informed a challenge for neurologists, and even more so for other healthcare practitioners who are involved in symptom evaluation and treatment. Multiple Sclerosis for the Non-Neurologist is an up-t

Multiple Sclerosis for the Non-Neurologi
โœ Mary Ann Picone ๐Ÿ“‚ Library ๐Ÿ“… 2019 ๐Ÿ› LWW ๐ŸŒ English

<span>Recent rapid changes in the field of multiple sclerosis management have made the task of staying well-informed a challenge for neurologists, and even more so for other healthcare practitioners who are involved in symptom evaluation and treatment. </span><span>Multiple Sclerosis for the Non-Neu

Multiple Sclerosis for the Practicing Ne
โœ Adnan Al-araji, Jose A., M.D., Ph.D. Cabrera-Gomez, Marninella, M.D. Clerico, Gi ๐Ÿ“‚ Library ๐Ÿ“… 2006 ๐Ÿ› Demos Medical Publishing ๐ŸŒ English

The Multiple Sclerosis International Foundation estimates that over 2.5 million people worldwide have multiple sclerosis. Throughout developed countries, increased attention has been paid to this disorder, due in large part to advanced imaging technology and the development of new therapeutic pharma

Multiple Sclerosis in Clinical Practice
โœ Stanley Van Den Noort, Nancy J. Holland ๐Ÿ“‚ Library ๐Ÿ“… 1999 ๐Ÿ› Demos Medical Publishing ๐ŸŒ English

Managing multiple sclerosis, with all the associated problems of a progressive chronic disease, requires special knowledge on the part of the clinician. From which drugs to prescribe for an acute attack, to the use of new drugs available to help control the disease process, to managing the myriad of